Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Twist Bioscience Corp
Report date April 01, 2021 · Filed April 07, 2021
Section 16 reporting ended · disclosed 2021-04-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,736 |
Reported balance
After 2021-04-01 transaction · row 1
1 source rowRow 1 · 2021-04-01 · Tax withholding · Disposed 190 · Balance 66,736 F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2021 Filed Apr 5, 2021 22:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 190 | $122.20 | $23,218.00 |
DisclosureSEC source: 0001214659-21-003956 · ownership.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,736 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 01, 2021 Filed Apr 7, 2021 14:50 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 190 | $122.20 | $23,218.00 |
DisclosureSEC source: 0001214659-21-003999 · marketforms-52189.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,736 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,167 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-003816 · marketforms-52156.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,177 Underlying: Common Stock · 1,167 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,167 | $112.28 | $131,030.76 |
DisclosureSEC source: 0001214659-21-003816 · marketforms-52156.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,926 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,167 | $26.66 | $31,112.22 |
DisclosureSEC source: 0001214659-21-003816 · marketforms-52156.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 377 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-003703 · marketforms-52140.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,261 Underlying: Common Stock · 377 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 377 | $114.39 | $43,125.03 |
DisclosureSEC source: 0001214659-21-003703 · marketforms-52140.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,926 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 377 | $8.82 | $3,325.14 |
DisclosureSEC source: 0001214659-21-003703 · marketforms-52140.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 620 | $0.00 Strike: $23.33 | $0.00 |
DisclosureSEC source: 0001214659-21-003502 · marketforms-52082.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,235 Underlying: Common Stock · 620 shares Expires 2029-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 620 | $132.50 | $82,150.00 |
DisclosureSEC source: 0001214659-21-003502 · marketforms-52082.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,926 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 620 | $23.33 | $14,464.60 |
DisclosureSEC source: 0001214659-21-003502 · marketforms-52082.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 669 | $0.00 Strike: $10.70 | $0.00 |
DisclosureSEC source: 0001214659-21-002778 · marketforms-51756.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,685 Underlying: Common Stock · 669 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 669 | $125.33 | $83,845.77 |
DisclosureSEC source: 0001214659-21-002778 · marketforms-51756.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,926 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 669 | $10.70 | $7,158.30 |
DisclosureSEC source: 0001214659-21-002778 · marketforms-51756.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 377 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-002670 · marketforms-51683.xml · derivative · entry 5 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,638 Underlying: Common Stock · 377 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,166 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-002670 · marketforms-51683.xml · derivative · entry 4 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,344 Underlying: Common Stock · 1,166 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,543 | $140.78 | $217,223.54 |
DisclosureSEC source: 0001214659-21-002670 · marketforms-51683.xml · nonDerivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,926 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 377 | $8.82 | $3,325.14 |
DisclosureSEC source: 0001214659-21-002670 · marketforms-51683.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:36 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,166 | $26.66 | $31,085.56 |
DisclosureSEC source: 0001214659-21-002670 · marketforms-51683.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 23:49 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 620 | $0.00 Strike: $23.33 | $0.00 |
DisclosureSEC source: 0001214659-21-002457 · marketforms-51650.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,855 Underlying: Common Stock · 620 shares Expires 2029-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 23:49 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 620 | $134.31 | $83,272.20 |
DisclosureSEC source: 0001214659-21-002457 · marketforms-51650.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,926 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 23:49 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 620 | $23.33 | $14,464.60 |
DisclosureSEC source: 0001214659-21-002457 · marketforms-51650.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:21 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 981 | $146.98 | $144,187.38 |
DisclosureSEC source: 0001214659-21-002316 · marketforms-51609.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,926 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:55 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 519 | $150.81 | $78,270.39 |
DisclosureSEC source: 0001214659-21-002297 · marketforms-51552.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,907 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 04, 2021 Filed Feb 8, 2021 22:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 668 | $0.00 Strike: $10.70 | $0.00 |
DisclosureSEC source: 0001214659-21-001443 · marketforms-51427.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,354 Underlying: Common Stock · 668 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2021 Filed Feb 8, 2021 22:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 668 | $191.52 | $127,935.36 |
DisclosureSEC source: 0001214659-21-001443 · marketforms-51427.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,200 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| February 04, 2021 Filed Feb 8, 2021 22:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 668 | $10.70 | $7,147.60 |
DisclosureSEC source: 0001214659-21-001443 · marketforms-51427.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:54 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,166 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-001200 · marketforms-51333.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,510 Underlying: Common Stock · 1,166 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:54 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,166 | $166.74 | $194,418.84 |
DisclosureSEC source: 0001214659-21-001200 · marketforms-51333.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,200 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:54 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,166 | $26.66 | $31,085.56 |
DisclosureSEC source: 0001214659-21-001200 · marketforms-51333.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 23:00 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 377 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-001090 · marketforms-51308.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,015 Underlying: Common Stock · 377 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 23:00 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 377 | $161.02 | $60,704.54 |
DisclosureSEC source: 0001214659-21-001090 · marketforms-51308.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,200 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 23:00 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 377 | $8.82 | $3,325.14 |
DisclosureSEC source: 0001214659-21-001090 · marketforms-51308.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 620 | $0.00 Strike: $23.33 | $0.00 |
DisclosureSEC source: 0001214659-21-000827 · marketforms-51261.xml · derivative · entry 5 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,475 Underlying: Common Stock · 620 shares Expires 2029-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 , and 1/48th of the shares subject to the option vest and become exerisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 620 | $193.00 | $119,660.00 |
DisclosureSEC source: 0001214659-21-000827 · marketforms-51261.xml · nonDerivative · entry 4 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,200 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 620 | $23.33 | $14,464.60 |
DisclosureSEC source: 0001214659-21-000827 · marketforms-51261.xml · nonDerivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 285 | $193.00 | $55,005.00 |
DisclosureSEC source: 0001214659-21-000827 · marketforms-51261.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,200 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 149 | $190.64 | $28,405.36 |
DisclosureSEC source: 0001214659-21-000827 · marketforms-51261.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,485 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 669 | $0.00 Strike: $10.70 | $0.00 |
DisclosureSEC source: 0001214659-21-000146 · marketforms-50803.xml · derivative · entry 7 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,022 Underlying: Common Stock · 669 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 669 | $138.61 | $92,730.09 |
DisclosureSEC source: 0001214659-21-000146 · marketforms-50803.xml · nonDerivative · entry 5 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,634 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 669 | $10.70 | $7,158.30 |
DisclosureSEC source: 0001214659-21-000146 · marketforms-50803.xml · nonDerivative · entry 4 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 153 | $141.29 | $21,617.37 |
DisclosureSEC source: 0001214659-21-000146 · marketforms-50803.xml · nonDerivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,634 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,166 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-000146 · marketforms-50803.xml · derivative · entry 6 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,676 Underlying: Common Stock · 1,166 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,166 | $152.13 | $177,383.58 |
DisclosureSEC source: 0001214659-21-000146 · marketforms-50803.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,787 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,166 | $26.66 | $31,085.56 |
DisclosureSEC source: 0001214659-21-000146 · marketforms-50803.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:53 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 377 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-010742 · marketforms-50726.xml · derivative · entry 6 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,392 Underlying: Common Stock · 377 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:53 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 377 | $167.10 | $62,996.70 |
DisclosureSEC source: 0001214659-20-010742 · marketforms-50726.xml · nonDerivative · entry 4 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,787 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 22:53 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 377 | $8.82 | $3,325.14 |
DisclosureSEC source: 0001214659-20-010742 · marketforms-50726.xml · nonDerivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 24, 2020 Filed Dec 29, 2020 22:53 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 620 | $0.00 Strike: $23.33 | $0.00 |
DisclosureSEC source: 0001214659-20-010742 · marketforms-50726.xml · derivative · entry 5 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,095 Underlying: Common Stock · 620 shares Expires 2029-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 24, 2020 Filed Dec 29, 2020 22:53 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 620 | $167.79 | $104,029.80 |
DisclosureSEC source: 0001214659-20-010742 · marketforms-50726.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,787 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.